Ambroxol, long used for coughs in Europe, stabilized symptoms and brain-damage markers in Parkinson’s dementia patients over ...

The results of experiments in mice models were "astounding," said biochemist Suzanne Pfeffer of Stanford University.

Stanford researchers discovered that dialing down an overactive enzyme, LRRK2, can regrow lost cellular “antennae” in key ...

A safe and affordable treatment to slow the advancement of Parkinson's dementia has emerged – in the form of a commonly ...

A breakthrough brain scan shows Parkinson’s drugs can misfire in the brain, helping some patients less than others. The fix?

Groundbreaking research by Sydney University found a new brain protein involved in Parkinson’s disease and a way to modify it ...

In a breakthrough study, scientists found that silencing a single overactive enzyme in the brain reversed early damage caused ...

Elizabeth Jonas first got interested in mitochondria by chance. In 1995, she was a postdoctoral researcher at Yale, working ...

A targeted drug therapy has shown potential to reverse cellular damage in Parkinson's disease by regenerating critical brain ...

Federal programs that support people with brain injury, such as HEADS UP and the National Concussion Surveillance System, are ...

Explore the latest research on Parkinson's and a key brain protein that may lead to new treatments for this common condition.